Investors / United States / Chugai Venture Fund
Chugai Venture Fund
Corporate VC · Boston, MA, United States · North America
Chugai Venture Fund is an investment firm and subsidiary of Chugai Pharmaceutical Co., Ltd. that invests in life sciences companies and provides funding and access to its parent company's expertise and resources.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechhealthcaredrug discoverytherapeuticsearly stage
Your fit with Chugai Venture Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsChugai Venture Fund lists 6 checked portfolio companies on its own site and is named in 5 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Black Opal Ventures, Brainstorm Ventures and California Innovation Fund.
Counts come from funding rounds that name Chugai Venture Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 100th | 67% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 20th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Black Opal Ventures | 1 |
| Brainstorm Ventures | 1 |
| California Innovation Fund | 1 |
| Cape Fear BioCapital | 1 |
| DFJ DragonFund | 1 |
| Draper Associates | 1 |
| Droia Ventures | 1 |
| Duke Capital Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Black Opal Ventures
Compare Chugai Venture Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Chugai Venture Fund| Date | Company | Stage |
|---|---|---|
| 17 Aug 2026 | Series A | |
| 19 Feb 2026 | Round Led | |
| 16 Sept 2025 | Series A | |
| 27 Aug 2025 | Series A | |
| 13 May 2025 | Series A |
Round details for Chugai Venture Fund
Amounts, full round histories and every co-investor in Chugai Venture Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Dualitas Therapeutics develops bispecific antibody therapies for autoimmune, allergic, and other immune and inflammatory diseases. | Healthcare & Biotech | Sept 2025Series A | Page + round | |
| Hyku Biosciences is developing small molecule therapeutics with novel mechanisms of action to potently inactivate proteins that drive disease progression. | Healthcare & Biotech | Portfolio page | ||
| Leal Therapeutics is developing neuro-metabolic therapeutics for high unmet need CNS disorders. | Healthcare & Biotech | Aug 2025Series A · 2 rounds | Page + round | |
| Repertoire Immune Medicines is discovering and developing immune medicines for patients with cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Stylus Medicine is developing in vivo genetic medicines to unlock cures. | Healthcare & Biotech | May 2025Series A | Page + round | |
| Ten63 Therapeutics designs therapeutics for diseases using generative chemistry and quantum-accurate simulation. | Healthcare & Biotech | Feb 2026Round | Page + round |
About this data
site last read 7 Nov 2026- Site
- chugaiventurefund.com
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 13 May 2025
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Chugai Venture Fund's profile as data
Pull Chugai Venture Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/chugaiventurefund.com
# also
GET /v1/firms/chugaiventurefund.com/portfolio
GET /v1/firms/chugaiventurefund.com/coinvestors
GET /v1/firms/chugaiventurefund.com/news